Healthcare provider profile · identity verified

Timothy Day, MD

Family Practice · WINAMAC, IN · NPI 1386178861

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	614	185
Levothyroxine Sodium	Levothyroxine Sodium	378	105
Amlodipine Besylate	Amlodipine Besylate	344	103
Losartan Potassium	Losartan Potassium	313	87
Lisinopril	Lisinopril	312	100
Omeprazole	Omeprazole	218	63
Furosemide	Furosemide	201	57
Albuterol Sulfate Hfa	Albuterol Sulfate	179	49
Pantoprazole Sodium	Pantoprazole Sodium	179	54
Tamsulosin Hcl	Tamsulosin Hcl	179	56
Gabapentin	Gabapentin	173	49
Hydrochlorothiazide	Hydrochlorothiazide	172	50
Metoprolol Succinate	Metoprolol Succinate	167	48
Metformin Hcl	Metformin Hcl	166	56
Carvedilol	Carvedilol	150	39
Metoprolol Tartrate	Metoprolol Tartrate	146	41
Meloxicam	Meloxicam	138	31
Sertraline Hcl	Sertraline Hcl	135	39
Lovastatin	Lovastatin	119	34
Pravastatin Sodium	Pravastatin Sodium	114	34
Simvastatin	Simvastatin	112	27
Metformin Hcl Er	Metformin Hcl	109	28
Escitalopram Oxalate	Escitalopram Oxalate	107	40
Rosuvastatin Calcium	Rosuvastatin Calcium	105	29
Alendronate Sodium	Alendronate Sodium	104	31
Prednisone	Prednisone	100	50
Potassium Chloride	Potassium Chloride	95	36
Clopidogrel	Clopidogrel Bisulfate	94	28
Allopurinol	Allopurinol	89	29
Tramadol Hcl	Tramadol Hcl	88	26
Ozempic	Semaglutide	84	18
Eliquis	Apixaban	83	24
Alprazolam	Alprazolam	78	22
Triamcinolone Acetonide	Triamcinolone Acetonide	77	43
Diclofenac Sodium	Diclofenac Sodium	67	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	15
Jardiance	Empagliflozin	65	17
Xarelto	Rivaroxaban	64	16
Glipizide	Glipizide	62	19
Cephalexin	Cephalexin	61	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	58	24
Montelukast Sodium	Montelukast Sodium	56	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	18
Atenolol	Atenolol	53	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	20
Enalapril Maleate	Enalapril Maleate	51	12
Fluticasone Propionate	Fluticasone Propionate	49	27
Glimepiride	Glimepiride	49	14
Famotidine	Famotidine	48	19
Zolpidem Tartrate	Zolpidem Tartrate	46	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	44	15
Trazodone Hcl	Trazodone Hcl	42	16
Ezetimibe	Ezetimibe	40	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Azithromycin	Azithromycin	39	31
Buspirone Hcl	Buspirone Hcl	39	15
Citalopram Hbr	Citalopram Hydrobromide	38	11
Spironolactone	Spironolactone	35	suppressed
Synthroid	Levothyroxine Sodium	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	11
Oxybutynin Chloride Er	Oxybutynin Chloride	32	12
Clonazepam	Clonazepam	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Glipizide Er	Glipizide	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	26
Warfarin Sodium	Warfarin Sodium	29	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	26	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Lorazepam	Lorazepam	25	suppressed
Ondansetron Odt	Ondansetron	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Topiramate	Topiramate	23	suppressed
Finasteride	Finasteride	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Naproxen	Naproxen	22	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Digoxin	Digoxin	19	suppressed
Baclofen	Baclofen	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	17
Mirtazapine	Mirtazapine	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Tradjenta	Linagliptin	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Levofloxacin	Levofloxacin	16	15
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Torsemide	Torsemide	16	suppressed
Budesonide Dr	Budesonide	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Entresto	Sacubitril/Valsartan	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Etodolac	Etodolac	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Primidone	Primidone	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sulindac	Sulindac	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error